ARWR logo

ARWR Net income

annual net income:

-$599.49M-$394.22M(-192.04%)
September 30, 2024

Summary

  • As of today (May 29, 2025), ARWR annual net profit is -$599.49 million, with the most recent change of -$394.22 million (-192.04%) on September 30, 2024.
  • During the last 3 years, ARWR annual net income has fallen by -$458.64 million (-325.63%).
  • ARWR annual net income is now -981.93% below its all-time high of $67.97 million, reached on September 30, 2019.

Performance

ARWR Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRincome statement metrics

quarterly net income:

$370.44M+$543.53M(+314.02%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ARWR quarterly net profit is $370.44 million, with the most recent change of +$543.53 million (+314.02%) on March 31, 2025.
  • Over the past year, ARWR quarterly net income has increased by +$495.75 million (+395.65%).
  • ARWR quarterly net income is now at all-time high.

Performance

ARWR quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRincome statement metrics

TTM net income:

-$143.97M+$495.75M(+77.49%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ARWR TTM net profit is -$143.97 million, with the most recent change of +$495.75 million (+77.49%) on March 31, 2025.
  • Over the past year, ARWR TTM net income has increased by +$326.82 million (+69.42%).
  • ARWR TTM net income is now -311.80% below its all-time high of $67.98 million, reached on September 30, 2019.

Performance

ARWR TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ARWR Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-192.0%+395.6%+69.4%
3 y3 years-325.6%+735.0%-28.8%
5 y5 years-981.9%+1967.5%-1610.4%

ARWR Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-325.6%at lowat high+314.0%-28.8%+77.5%
5 y5-year-981.9%at lowat high+314.0%-1610.4%+77.5%
alltimeall time-981.9%at lowat high+314.0%-311.8%+77.5%

ARWR Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
$370.44M(-314.0%)
-$143.97M(-77.5%)
Dec 2024
-
-$173.09M(+1.5%)
-$639.71M(+6.7%)
Sep 2024
-$599.49M(+192.0%)
-$170.54M(-0.2%)
-$599.49M(+11.3%)
Jun 2024
-
-$170.79M(+36.3%)
-$538.64M(+14.4%)
Mar 2024
-
-$125.30M(-5.7%)
-$470.79M(+58.6%)
Dec 2023
-
-$132.86M(+21.1%)
-$296.81M(+44.6%)
Sep 2023
-$205.28M(+16.6%)
-$109.68M(+6.5%)
-$205.28M(+13.3%)
Jun 2023
-
-$102.95M(-311.5%)
-$181.11M(+20.6%)
Mar 2023
-
$48.67M(-217.8%)
-$150.21M(-2.8%)
Dec 2022
-
-$41.33M(-51.7%)
-$154.52M(-12.2%)
Sep 2022
-$176.06M(+25.0%)
-$85.51M(+18.7%)
-$176.06M(+14.4%)
Jun 2022
-
-$72.05M(-262.4%)
-$153.93M(+37.7%)
Mar 2022
-
$44.37M(-170.6%)
-$111.80M(-38.9%)
Dec 2021
-
-$62.87M(-0.8%)
-$182.99M(+29.9%)
Sep 2021
-$140.85M(+66.6%)
-$63.37M(+111.8%)
-$140.85M(+11.9%)
Jun 2021
-
-$29.92M(+11.6%)
-$125.91M(+14.9%)
Mar 2021
-
-$26.82M(+29.4%)
-$109.59M(+6.8%)
Dec 2020
-
-$20.73M(-57.2%)
-$102.61M(+21.4%)
Sep 2020
-$84.55M(-224.4%)
-$48.43M(+255.8%)
-$84.55M(+246.3%)
Jun 2020
-
-$13.61M(-31.4%)
-$24.41M(-356.1%)
Mar 2020
-
-$19.84M(+642.1%)
$9.53M(-82.1%)
Dec 2019
-
-$2.67M(-122.8%)
$53.26M(-21.6%)
Sep 2019
$67.97M(-224.8%)
$11.71M(-42.4%)
$67.98M(+49.4%)
Jun 2019
-
$20.34M(-14.9%)
$45.51M(+375.7%)
Mar 2019
-
$23.90M(+98.5%)
$9.57M(-132.7%)
Dec 2018
-
$12.04M(-211.9%)
-$29.21M(-46.3%)
Sep 2018
-$54.45M(+58.4%)
-$10.76M(-31.0%)
-$54.45M(+0.1%)
Jun 2018
-
-$15.61M(+4.8%)
-$54.42M(+22.8%)
Mar 2018
-
-$14.88M(+12.8%)
-$44.33M(+24.9%)
Dec 2017
-
-$13.20M(+23.0%)
-$35.49M(+3.2%)
Sep 2017
-$34.38M(-57.9%)
-$10.73M(+94.4%)
-$34.38M(-25.0%)
Jun 2017
-
-$5.52M(-8.7%)
-$45.87M(-23.3%)
Mar 2017
-
-$6.04M(-50.0%)
-$59.77M(-19.8%)
Dec 2016
-
-$12.09M(-45.6%)
-$74.54M(-8.8%)
Sep 2016
-$81.72M(-11.1%)
-$22.22M(+14.4%)
-$81.72M(-3.0%)
Jun 2016
-
-$19.42M(-6.7%)
-$84.24M(+4.3%)
Mar 2016
-
-$20.82M(+8.1%)
-$80.76M(-8.9%)
Dec 2015
-
-$19.26M(-22.1%)
-$88.63M(-3.6%)
Sep 2015
-$91.94M(+56.8%)
-$24.74M(+55.3%)
-$91.94M(+2.6%)
Jun 2015
-
-$15.94M(-44.4%)
-$89.63M(+5.0%)
Mar 2015
-
-$28.68M(+27.1%)
-$85.32M(+20.9%)
Dec 2014
-
-$22.58M(+0.6%)
-$70.58M(+20.4%)
Sep 2014
-$58.63M(+88.3%)
-$22.43M(+92.9%)
-$58.63M(+17.5%)
Jun 2014
-
-$11.63M(-16.6%)
-$49.89M(+12.5%)
Mar 2014
-
-$13.94M(+31.2%)
-$44.34M(+19.3%)
Dec 2013
-
-$10.63M(-22.4%)
-$37.16M(+19.3%)
Sep 2013
-$31.14M(+47.4%)
-$13.69M(+125.2%)
-$31.14M(+36.8%)
Jun 2013
-
-$6.08M(-10.0%)
-$22.76M(-7.8%)
Mar 2013
-
-$6.76M(+46.5%)
-$24.68M(+6.1%)
Dec 2012
-
-$4.61M(-13.2%)
-$23.25M(+10.1%)
Sep 2012
-$21.13M
-$5.31M(-33.5%)
-$21.13M(+13.6%)
Jun 2012
-
-$7.99M(+49.8%)
-$18.59M(+49.7%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$5.34M(+114.7%)
-$12.42M(+197.3%)
Dec 2011
-
-$2.49M(-10.5%)
-$4.18M(+33.5%)
Sep 2011
-$3.13M(-45.8%)
-$2.78M(+52.6%)
-$3.13M(+32.8%)
Jun 2011
-
-$1.82M(-162.6%)
-$2.36M(+159.6%)
Mar 2011
-
$2.91M(-302.1%)
-$907.70K(-84.0%)
Dec 2010
-
-$1.44M(-28.3%)
-$5.67M(-1.9%)
Sep 2010
-$5.77M(-70.1%)
-$2.00M(+440.0%)
-$5.77M(-20.1%)
Jun 2010
-
-$371.10K(-80.0%)
-$7.23M(-23.0%)
Mar 2010
-
-$1.85M(+20.0%)
-$9.39M(-26.8%)
Dec 2009
-
-$1.54M(-55.3%)
-$12.82M(-33.6%)
Sep 2009
-$19.31M(-28.7%)
-$3.46M(+36.8%)
-$19.31M(-21.2%)
Jun 2009
-
-$2.53M(-52.2%)
-$24.51M(-16.9%)
Mar 2009
-
-$5.29M(-34.1%)
-$29.48M(-1.4%)
Dec 2008
-
-$8.03M(-7.3%)
-$29.89M(+10.3%)
Sep 2008
-$27.09M(-9.5%)
-$8.66M(+15.4%)
-$27.09M(+4.2%)
Jun 2008
-
-$7.50M(+31.7%)
-$26.00M(-16.1%)
Mar 2008
-
-$5.69M(+8.8%)
-$30.98M(-1.5%)
Dec 2007
-
-$5.23M(-30.9%)
-$31.46M(+5.1%)
Sep 2007
-$29.93M(+57.6%)
-$7.57M(-39.3%)
-$29.93M(+4.1%)
Jun 2007
-
-$12.48M(+102.1%)
-$28.76M(+41.0%)
Mar 2007
-
-$6.17M(+66.5%)
-$20.40M(+5.0%)
Dec 2006
-
-$3.71M(-42.1%)
-$19.42M(+3.0%)
Sep 2006
-$19.00M(+177.1%)
-$6.41M(+55.8%)
-$18.85M(+23.1%)
Jun 2006
-
-$4.11M(-20.9%)
-$15.32M(+8.1%)
Mar 2006
-
-$5.19M(+65.6%)
-$14.17M(+69.5%)
Dec 2005
-
-$3.14M(+9.2%)
-$8.36M(+23.2%)
Sep 2005
-$6.85M(+171.1%)
-$2.87M(-3.1%)
-$6.79M(+25.2%)
Jun 2005
-
-$2.97M(-581.5%)
-$5.42M(+75.3%)
Mar 2005
-
$615.90K(-139.4%)
-$3.09M(-20.4%)
Dec 2004
-
-$1.56M(+3.6%)
-$3.88M(+53.7%)
Sep 2004
-$2.53M(+2555.7%)
-$1.51M(+136.3%)
-$2.53M(+177.2%)
Jun 2004
-
-$638.20K(+262.8%)
-$911.90K(+178.7%)
Mar 2004
-
-$175.90K(-14.6%)
-$327.20K(+27.8%)
Dec 2003
-
-$205.90K(-290.5%)
-$256.10K(+168.7%)
Sep 2003
-$95.20K(-61.3%)
$108.10K(-302.1%)
-$95.30K(-66.9%)
Jun 2003
-
-$53.50K(-49.0%)
-$288.10K(-10.7%)
Mar 2003
-
-$104.80K(+132.4%)
-$322.70K(+41.5%)
Dec 2002
-
-$45.10K(-46.8%)
-$228.10K(-7.4%)
Sep 2002
-$246.20K(+32.5%)
-$84.70K(-3.9%)
-$246.30K(+10.7%)
Jun 2002
-
-$88.10K(+763.7%)
-$222.50K(+33.2%)
Mar 2002
-
-$10.20K(-83.9%)
-$167.00K(-19.8%)
Dec 2001
-
-$63.30K(+3.9%)
-$208.20K(+12.1%)
Sep 2001
-$185.80K(+35.0%)
-$60.90K(+86.8%)
-$185.70K(+106.3%)
Jun 2001
-
-$32.60K(-36.6%)
-$90.00K(-21.7%)
Mar 2001
-
-$51.40K(+26.0%)
-$115.00K(-2.3%)
Dec 2000
-
-$40.80K(-217.2%)
-$117.70K(-14.5%)
Sep 2000
-$137.60K(-123.2%)
$34.80K(-160.4%)
-$137.60K(-20.2%)
Jun 2000
-
-$57.60K(+6.5%)
-$172.40K(+50.2%)
Mar 2000
-
-$54.10K(-10.9%)
-$114.80K(+89.1%)
Dec 1999
-
-$60.70K
-$60.70K
Sep 1999
$593.00K(-459.4%)
-
-
Sep 1998
-$165.00K(-80.7%)
-
-
Sep 1997
-$854.50K
-
-

FAQ

  • What is Arrowhead Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals annual net income year-on-year change?
  • What is Arrowhead Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals quarterly net income year-on-year change?
  • What is Arrowhead Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals TTM net income year-on-year change?

What is Arrowhead Pharmaceuticals annual net profit?

The current annual net income of ARWR is -$599.49M

What is the all time high annual net income for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high annual net profit is $67.97M

What is Arrowhead Pharmaceuticals annual net income year-on-year change?

Over the past year, ARWR annual net profit has changed by -$394.22M (-192.04%)

What is Arrowhead Pharmaceuticals quarterly net profit?

The current quarterly net income of ARWR is $370.44M

What is the all time high quarterly net income for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high quarterly net profit is $370.44M

What is Arrowhead Pharmaceuticals quarterly net income year-on-year change?

Over the past year, ARWR quarterly net profit has changed by +$495.75M (+395.65%)

What is Arrowhead Pharmaceuticals TTM net profit?

The current TTM net income of ARWR is -$143.97M

What is the all time high TTM net income for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high TTM net profit is $67.98M

What is Arrowhead Pharmaceuticals TTM net income year-on-year change?

Over the past year, ARWR TTM net profit has changed by +$326.82M (+69.42%)
On this page